Skip to main content
SpringerLink
Log in

Diagnosis and Management of Gastrointestinal Lymphoma

  • Chapter
Endoscopic Oncology

Abstract

Primary gastrointestinal (GI) tract lymphomas account for 1–4% of gastric, small intestinal, and colonic malignancies. They arise from mucosa-associated lymphoid tissue (MALT) and most are B-cell non-Hodgkin’s lymphomas. T-cell lymphomas of the bowel are usually associated with celiac disease. The GI tract is the most common site for extranodal non-Hodgkin’s lymphomas with the stomach accounting for more than 75%. Accurate staging helps with prognosis and management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Paryani S, Hoppe RT, Burke JS, et al. Extralymphatic involvement in diffuse non-Hodgkin’s lymphoma. J Clin Oncol 1983; 1(11):682–688.

    PubMed  CAS  Google Scholar 

  2. Isaacson PG. Gastrointestinal lymphoma. Hum Pathol 1994; 25(10): 1020–1029.

    Article  PubMed  CAS  Google Scholar 

  3. Ehrlich AN, Stalder G, Geller W, Sherlock P. Gastrointestinal manifestations of malignant lymphoma. Gastroenterology 1968; 54(6): 1115–1121.

    PubMed  CAS  Google Scholar 

  4. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17(12):3835–3849.

    PubMed  CAS  Google Scholar 

  5. Takeshita K, Ashikawa T, Watanuki S, et al. Endoscopic and clinicopathological features of primary gastric lymphoma. Hepatogastroenterology 1993; 40(5):485–490.

    PubMed  CAS  Google Scholar 

  6. Savides TJ, Jensen DM, Cohen J, et al. Severe upper gastrointestinal tumor bleeding: endoscopic findings, treatment, and outcome. Endoscopy 1996; 28(2):244–248.

    PubMed  CAS  Google Scholar 

  7. Suekane H, Iida M, Yao T, Matsumoto T, Masuda Y, Fujishima M. Endoscopic ultrasonography in primary gastric lymphoma: correlation with endoscopic and histologic findings. Gastrointest Endosc 1993; 39(2):39–145.

    Google Scholar 

  8. Caleti G, Ferrar A, Brocci E, Barbara L. Accuracy of endoscopic ultrasonography in the diagnosis and staging of gastric cancer and lymphoma. Surgery 1993; 113(1):14–27.

    Google Scholar 

  9. Hartmann D, Schilling D, Rebel M, et al. Diagnosis of a high-grade B-cell lymphoma of the small bowel by means of wireless capsule endoscopy. Z Gastroenterol 2003; 41(2):171–174.

    Article  PubMed  CAS  Google Scholar 

  10. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 2001; 19(18):3861–3873.

    PubMed  CAS  Google Scholar 

  11. Ahmad A, Govil Y, Frank BB. Gastric mucosa-associated lymphoid tissue lymphoma. Am J Gastroenterol 2003; 98(5):975–986.

    Article  PubMed  Google Scholar 

  12. Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998; 338(12):804–810.

    Article  PubMed  CAS  Google Scholar 

  13. Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992; 339(8797):834–835.

    Article  PubMed  CAS  Google Scholar 

  14. Eck M, Schmausser B, Haas R, Greiner A, Czub S, Muller-Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112(5):1482–1486.

    Article  PubMed  CAS  Google Scholar 

  15. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330(18):1267–1271.

    Article  PubMed  CAS  Google Scholar 

  16. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338(8776): 1175, 1176.

    Article  PubMed  CAS  Google Scholar 

  17. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342(8871):575–577.

    Article  PubMed  CAS  Google Scholar 

  18. Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and post-treatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996; 87(4):1255–1260.

    PubMed  CAS  Google Scholar 

  19. Weber DM, Dimopoulos MA, Anandu DP, Pugh WC, Steinbach G. Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 1994; 107(6):1835–1838.

    PubMed  CAS  Google Scholar 

  20. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122(10):767–769.

    PubMed  CAS  Google Scholar 

  21. Carlson SJ, Yokoo H, Vanagunas A. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori. Jama 1996; 275(12):937–939.

    Article  PubMed  CAS  Google Scholar 

  22. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999; 131(2):88–95.

    PubMed  CAS  Google Scholar 

  23. Stolte M, Bayerdorffer E, Morgner A, et al. Helicobacter and gastric MALT lymphoma. Gut 2002; 50Suppl 3:III19–III24.

    PubMed  Google Scholar 

  24. Taal BG, Boot H, van Heerde P, de Jong D, Hart AA, Burgers JM. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut 1996; 39(4):556–561.

    Article  PubMed  CAS  Google Scholar 

  25. Seifert E, Schulte F, Weismuller J, de Mas CR, Stolte M. Endoscopic and bioptic diagnosis of malignant non-Hodgkin’s lymphoma of the stomach. Endoscopy 1993; 25(8):497–501.

    Article  PubMed  CAS  Google Scholar 

  26. Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95(3):802–806.

    PubMed  CAS  Google Scholar 

  27. Levy M, Hammel P, Lamarque D, et al. Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically. Gastrointest Endosc 1997; 46(4):328–333.

    Article  PubMed  CAS  Google Scholar 

  28. Sackmann M, Morgner A, Rudolph B, et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997; 113(4):1087–1090.

    Article  PubMed  CAS  Google Scholar 

  29. Abbondanzo SL, Sobin LH. Gastric “pseudolymphoma”: a retrospective morphologic and immunophenotypic study of 97 cases. Cancer 1997; 79(9):1656–1663.

    Article  PubMed  CAS  Google Scholar 

  30. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345(8965):1591–1594.

    Article  PubMed  CAS  Google Scholar 

  31. Bertoni F, Conconi A, Capella C, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002; 99(7):2541–2544.

    Article  PubMed  CAS  Google Scholar 

  32. Morgner A, Miehlke S, Fischbach W, et al. Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol 2001; 19(7):2041–2048.

    PubMed  CAS  Google Scholar 

  33. Chen LT, Lin JT, Shyu RY, et al. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001; 19(22):4245–4251.

    PubMed  CAS  Google Scholar 

  34. Nagashima R, Takeda H, Maeda K, Ohno S, Takahashi T. Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. Gastroenterology 1996; 111(6):1674–1678.

    Article  PubMed  CAS  Google Scholar 

  35. Matsumoto T, Iida M, Shimizu M. Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet 1997; 350(9071):115–116.

    Article  PubMed  CAS  Google Scholar 

  36. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001; 357(9249):39,40.

    Article  PubMed  CAS  Google Scholar 

  37. Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002; 122(5):1286–1294.

    Article  PubMed  CAS  Google Scholar 

  38. Du MQ, Peng H, Liu H, et al. BCL10 gene mutation in lymphoma. Blood 2000; 95(12):3885–3890.

    PubMed  CAS  Google Scholar 

  39. Alpen B, Neubauer A, Dierlamm J, et al. Translocation t(11; 18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000; 95(12):4014,4015.

    PubMed  CAS  Google Scholar 

  40. Raderer M, Jager G, Brugger S, et al. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 2003; 65(4):306–310.

    Article  PubMed  CAS  Google Scholar 

  41. Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102(8):2741–2745.

    Article  PubMed  CAS  Google Scholar 

  42. Ishihara R, Tatsuta M, Iishi H, Uedo N, Narahara H, Ishiguro S. Usefulness of endoscopic appearance for choosing a biopsy target site and determining complete remission of primary gastric lymphoma of mucosa-associated lymphoid tissue after eradication of Helicobacter pylori infection. Am J Gastroenterol 2002; 97(3):772–774.

    Article  PubMed  Google Scholar 

  43. Urakami Y, Sano T, Begum S, Endo H, Kawamata H, Oki Y. Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. J Gastroenterol Hepatol 2000; 15(10):1113–1119.

    Article  PubMed  CAS  Google Scholar 

  44. De Wolf-Peeters C, Achten R. The histogenesis of large-cell gastric lymphomas. Histopathology 1999; 34(1):71–75.

    Article  PubMed  Google Scholar 

  45. Yoshino T, Omonishi K, Kobayashi K, et al. Clinicopathological features of gastric mucosa associated lymphoid tissue (MALT) lymphomas: high grade transformation and comparison with diffuse large B cell lymphomas without MALT lymphoma features. J Clin Pathol 2000; 53(3): 187–190.

    Article  PubMed  CAS  Google Scholar 

  46. Salles G, Herbrecht R, Tilly H, et al. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d’Etude des Lymphomes Agressifs. Am J Med 1991; 90(1):77–84.

    Article  PubMed  CAS  Google Scholar 

  47. Ferreri AJ, Cordio S, Ponzoni M, Villa E. Non-surgical treatment with primary chemotherapy, with or without radiation therapy, of stage I-II high-grade gastric lymphoma. Leuk Lymphoma 1999; 33(5-6):531–541.

    PubMed  CAS  Google Scholar 

  48. Popescu RA, Wotherspoon AC, Cunningham D, Norman A, Prendiville J, Hill ME. Surgery plus chemotherapy or chemotherapy alone for primary intermediate-and high-grade gastric non-Hodgkin’s lymphoma: the Royal Marsden Hospital experience. Eur J Cancer 1999; 35(6):928–934.

    Article  PubMed  CAS  Google Scholar 

  49. Taal BG, den Hartog Jager FC, Burgers JM, van Heerde P, Tio TL. Primary non-Hodgkin’s lymphoma of the stomach: changing aspects and therapeutic choices. Eur J Cancer Clin Oncol 1989; 25(3): 439–450.

    Article  PubMed  CAS  Google Scholar 

  50. Domizio P, Owen RA, Shepherd NA, Talbot IC, Norton AJ. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol 1993; 17(5):429–442.

    PubMed  CAS  Google Scholar 

  51. Ruskone-Fourmestraux A, Delmer A, Lavergne A, et al. Multiple lymphomatous polyposis of the gastrointestinal tract: prospective clinicopathologic study of 31 cases. Groupe D’etude des Lymphomes Digestifs. Gastroenterology 1997; 112(1):7–16.

    Article  PubMed  CAS  Google Scholar 

  52. Khouri IF, Romaguera J, Kantarjian H, et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 1998; 16(12):3803–3809.

    PubMed  CAS  Google Scholar 

  53. Jermann M, Jost LM, Taverna C, et al. Rituximab-EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase n study. Ann Oncol 2004; 15(3):511–516.

    Article  PubMed  CAS  Google Scholar 

  54. Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350(3):239–248.

    Article  PubMed  CAS  Google Scholar 

  55. Isaacson PG, Dogan A, Price SK, Spencer J. Immunoproliferative small-intestinal disease. An immunohistochemical study. Am J Surg Pathol 1989; 13(12):1023–1033.

    Article  PubMed  CAS  Google Scholar 

  56. Salem P, el-Hashimi L, Anaissie E, et al. Primary small intestinal lymphoma in adults. A comparative study of IPSID versus non-IPSID in the Middle East. Cancer 1987; 59(9):1670–1676.

    Article  PubMed  CAS  Google Scholar 

  57. Khojasteh A, Haghshenass M, Haghighi P. Current concepts immunoproliferative small intestinal disease. A “Third-World lesion”. N Engl J Med 1983; 308(23):1401–1415.

    Article  PubMed  CAS  Google Scholar 

  58. Akbulut H, Soykan I, Yakaryilmaz F, et al. Five-year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience. Cancer 1997; 80(1):8–14.

    Article  PubMed  CAS  Google Scholar 

  59. Fine KD, Stone MJ. Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis. Am J Gastroenterol 1999; 94(5):1139–1152.

    PubMed  CAS  Google Scholar 

  60. el Saghir NS, Jessen K, Mass RE, et al. Combination chemotherapy for primary small intestinal lymphoma in the Middle East. Eur J Cancer Clin Oncol 1989; 25(5):851–856.

    Article  PubMed  Google Scholar 

  61. Ziegler JL. Burkitt’s lymphoma. N Engl J Med 1981; 305(13): 735–745.

    Article  PubMed  CAS  Google Scholar 

  62. Anaissie E, Geha S, Allam C, Jabbour J, Khalyl M, Salem P. Burkitt’s lymphoma in the Middle East. A study of 34 cases. Cancer 1985; 56(10):2539–2543.

    Article  PubMed  CAS  Google Scholar 

  63. Magrath I. The pathogenesis of Burkitt’s lymphoma. Adv Cancer Res 1990; 55:133–270.

    Article  PubMed  CAS  Google Scholar 

  64. Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80(1):8–20.

    PubMed  CAS  Google Scholar 

  65. Patte C, Philip T, Rodary C, et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991; 9(1):123–132.

    PubMed  CAS  Google Scholar 

  66. Isaacson PG. Gastrointestinal lymphomas of T-and B-cell types. Mod Pathol 1999; 12(2):151–158.

    PubMed  CAS  Google Scholar 

  67. Isaacson PG. Relation between cryptic intestinal lymphoma and refractory sprue. Lancet 2000; 356(9225):178,179.

    Article  PubMed  CAS  Google Scholar 

  68. Ryan BM, Kelleher D. Refractory celiac disease. Gastroenterology 2000; 119(1):243–251.

    Article  PubMed  CAS  Google Scholar 

  69. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol 1997; 151(2):493–498.

    PubMed  CAS  Google Scholar 

  70. Cooper BT, Holmes GK, Ferguson R, Cooke WT. Celiac disease and malignancy. Medicine (Baltimore) 1980; 59(4):249–261.

    CAS  Google Scholar 

  71. Catassi C, Fabiani E, Corrao G, et al. Risk of non-Hodgkin lymphoma in celiac disease. Jama 2002; 287(11):1413–1419.

    Article  PubMed  Google Scholar 

  72. Egan LJ, Walsh SV, Stevens FM, Connolly CE, Egan EL, McCarthy CF. Celiac-associated lymphoma. A single institution experience of 30 cases in the combination chemotherapy era. J Clin Gastroenterol 1995; 21(2):123–129.

    Article  PubMed  CAS  Google Scholar 

  73. Gale J, Simmonds PD, Mead GM, Sweetenham JW, Wright DH. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000; 18(4):795–803.

    PubMed  CAS  Google Scholar 

  74. Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323(25):1723–1728.

    Article  PubMed  CAS  Google Scholar 

  75. Milpied N, Vasseur B, Parquet N, et al. Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 2000; 11Suppl 1:113–116.

    Article  PubMed  Google Scholar 

  76. Cote TR, Biggar RJ, Rosenberg PS, et al. Non-Hodgkin’s lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 1997; 73(5):645–650.

    Article  PubMed  CAS  Google Scholar 

  77. Sandler AS, Kaplan LD. Diagnosis and management of systemic non-Hodgkin’s lymphoma in HIV disease. Hematol Oncol Clin North Am 1996; 10(5):1111–1124.

    Article  PubMed  CAS  Google Scholar 

  78. Place RJ, Huber PJ, Simmang CL. Anorectal lymphoma and AIDS: an outcome analysis. J Surg Oncol 2000; 73(1):1–4; discussion 5.

    Article  PubMed  CAS  Google Scholar 

  79. Spina M, Vaccher E, Carbone A, Tirelli U. Neoplastic complications of HIV infection. Ann Oncol 1999; 10(11):1271–1286.

    Article  PubMed  CAS  Google Scholar 

  80. Devaney K, Jaffe ES. The surgical pathology of gastrointestinal Hodgkin’s disease. Am J Clin Pathol 1991; 95(6):794–801.

    PubMed  CAS  Google Scholar 

  81. Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas 1994; 9(5):662–667.

    Article  PubMed  CAS  Google Scholar 

  82. Nishimura R, Takakuwa T, Hoshida Y, Tsujimoto M, Aozasa K. Primary pancreatic lymphoma: clinicopathological analysis of 19 cases from Japan and review of the literature. Oncology 2001; 60(4):322–329.

    Article  PubMed  CAS  Google Scholar 

  83. Blackledge G, Bush H, Dodge OG, Crowther D. A study of gastrointestinal lymphoma. Clin Oncol 1979; 5(3):209–219.

    PubMed  CAS  Google Scholar 

  84. Rohatiner A, d’Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994; 5(5):397–400.

    PubMed  CAS  Google Scholar 

  85. Ruskone-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon A, Dd Jong D. Paris staging system for primary gastrointestinal lymphomas. Gut 2003; 52(6):912,913.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, University of California, San Diego, CA

    John G. Kuldau MD & Thomas J. Savides MD

  2. Division of Hematology/Oncology, University of California, San Diego, CA

    Peter R. Holman MD

Authors
  1. John G. Kuldau MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter R. Holman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Thomas J. Savides MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health and Science University, Portland, OR

    Douglas O. Faigel MD, FACG, FASGE (Associate Professor of Medicine, Director of Endoscopy) (Associate Professor of Medicine, Director of Endoscopy)

  2. Hospital of the University of Pennsylvania, Philadelphia, PA

    Michael L. Kochman MD, FACP, FASGE (Professor of Medicine and Surgery, Co-Director Gastrointestinal Oncology) (Professor of Medicine and Surgery, Co-Director Gastrointestinal Oncology)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Kuldau, J.G., Holman, P.R., Savides, T.J. (2006). Diagnosis and Management of Gastrointestinal Lymphoma. In: Faigel, D.O., Kochman, M.L. (eds) Endoscopic Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-172-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-172-7_13

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-532-3

  • Online ISBN: 978-1-59745-172-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation